Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation
Christoph Reinhardt, … , Steffen Massberg, Bernd Engelmann
Christoph Reinhardt, … , Steffen Massberg, Bernd Engelmann
Published February 14, 2008
Citation Information: J Clin Invest. 2008;118(3):1110-1122. https://doi.org/10.1172/JCI32376.
View: Text | PDF
Research Article Article has an altmetric score of 5

Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation

  • Text
  • PDF
Abstract

The activation of initiator protein tissue factor (TF) is likely to be a crucial step in the blood coagulation process, which leads to fibrin formation. The stimuli responsible for inducing TF activation are largely undefined. Here we show that the oxidoreductase protein disulfide isomerase (PDI) directly promotes TF-dependent fibrin production during thrombus formation in vivo. After endothelial denudation of mouse carotid arteries, PDI was released at the injury site from adherent platelets and disrupted vessel wall cells. Inhibition of PDI decreased TF-triggered fibrin formation in different in vivo murine models of thrombus formation, as determined by intravital fluorescence microscopy. PDI infusion increased — and, under conditions of decreased platelet adhesion, PDI inhibition reduced — fibrin generation at the injury site, indicating that PDI can directly initiate blood coagulation. In vitro, human platelet–secreted PDI contributed to the activation of cryptic TF on microvesicles (microparticles). Mass spectrometry analyses indicated that part of the extracellular cysteine 209 of TF was constitutively glutathionylated. Mixed disulfide formation contributed to maintaining TF in a state of low functionality. We propose that reduced PDI activates TF by isomerization of a mixed disulfide and a free thiol to an intramolecular disulfide. Our findings suggest that disulfide isomerases can act as injury response signals that trigger the activation of fibrin formation following vessel injury.

Authors

Christoph Reinhardt, Marie-Luise von Brühl, Davit Manukyan, Lenka Grahl, Michael Lorenz, Berid Altmann, Silke Dlugai, Sonja Hess, Ildiko Konrad, Lena Orschiedt, Nigel Mackman, Lloyd Ruddock, Steffen Massberg, Bernd Engelmann

×

Figure 2

Specific exposure of PDI in the wounded area of the vessel wall.

Options: View larger image (or click on image) Download as PowerPoint
TF activation requires reduced PDI.
(A) TF activation by PDI. TF-express...
(A) Vessel injury causes appearance of intraluminal PDI in association with platelets. Fifteen minutes after ligation, vessel segments containing the injured area were excised and subjected to immunohistochemistry using an Alexa Fluor 594–labeled anti-PDI antibody. Platelets were stained with Alexa Fluor 488–labeled anti-CD41 antibody, and nuclei were visualized with DAPI. Arrows indicate PDI located in the vessel wall. Arrowheads show platelet-associated PDI. In parallel, the vessel segments were exposed to labeled isotype control antibodies. (B) PDI exposure at vessel injury site. Alexa Fluor 488–labeled anti-PDI antibody (or Alexa Fluor 488–labeled control antibody) was infused into WT and thrombocytopenic (platelet-depleted) mice (22) before and 15 and 25 minutes after vessel injury. The distribution of the labels at the injury location was visualized by intravital microscopy. Values obtained with anti-PDI antibody were normalized to values obtained with control antibody. #P < 0.05 compared with pre-injury; *P < 0.05 compared with control. n = 6.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
116 readers on Mendeley
See more details